Naltrexone Versus Acamprosate: One Year Follow-Up Of Alcohol Dependence Treatment

Alcohol and Alcoholism 2001, 36: 419-425; doi: 10.1093/alcalc/36.5.419 There were errors in Table 2 and Figure 2 in the published version of this article. In line 7 of Table 2, ‘Subjects who relapsed during the study’ should read ‘Subjects who did not relapse during the study’. There were also some errors in the data in Figure 2, which should also show that 41% and 17% (naltrexone and acamprosate respectively) had not relapsed: a corrected figure is included here. Survival analysis to first relapse (*) Five or more drinks per day The authors apologise for these errors.